From trials to programmatic scale-up: treatment outcomes of rifampicin-resistant tuberculosis during transition to short oral regimens in Vietnam (2021–2022)
During the transition from injectable-containing to all-oral short regimens, nationwide data showed 71.2% RR-TB treatment success in Vietnam. The wider use of STRs and addressing LTFU may further improve outcomes. More robust and better managed long regimens are needed for those not eligible for any STR.
Authors
- Tom Decroo (ORCID: https://orcid.org/0000-0002-1205-1484)
- Steven Callens (ORCID: https://orcid.org/0000-0002-7245-527X)
- Hoa Binh Nguyen (ORCID: https://orcid.org/0000-0002-1543-4907)
- Hoàng Thị Thanh Thủy (ORCID: https://orcid.org/0000-0003-0474-7091)
- Luong Van Dinh (ORCID: https://orcid.org/0000-0001-5145-3657)
- Nguyen Viet Nhung (ORCID: https://orcid.org/0000-0002-5447-133X)
- Nguyen Thi Mai Phuong
Institutions
- Vietnam National University Ho Chi Minh City (VN)
- Vietnam National University, Hanoi (VN)
- Ghent University Hospital (BE)
- Antwerp University Hospital (BE)
- Hanoi Medical University Hospital (VN)
- Hospital for Tropical Diseases (VN)
- Hanoi Lung Hospital (VN)
- Instituut voor Tropische Geneeskunde (BE)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-17
- DOI
- https://doi.org/10.1016/j.ijid.2025.108222
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40